Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares — Filings & Documents (NASDAQ:KNSA) — Page 10 | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

2018

Current report, Q2 FY2018

Kiniksa Pharmaceuticals International, Plc current report, Q2 FY2018

1
2
3
4
5
6
7
8
9
10

News

TGTX Stock Outperforms 95% of Stocks. Here's Why.

Three Biotech Stocks Stick Out With Their Stellar Charts

Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Kiniksa Pharmaceuticals International, plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-07-31

Stock Market Rises Amid Apple, Amazon, Meta, Microsoft Earnings, Soaring Yields: Weekly Review

MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth

Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises

Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?

Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates

EU Clears AZN's Etcamah Combo for First-Line ER-Positive Breast Cancer